Natasha Kyprianou

8PUBLICATIONS
14CO-AUTHORS
Molecular targetsHaematological tumoursMedical infection agents (incl. prions)Infant and child healthCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 17, 2026
Intersection of phenotypic plasticity and anoikis enhances therapeutic vulnerability in prostate cancer.

|May 08, 2024
Prostate cancer incidence and mortality in men exposed to α1-adrenergic receptor antagonists.

Lars Björnebo, Shirin Razdan, Andrea Discacciati

|Jan 09, 2024
Link between circadian rhythm and benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS).

Dana Cavanaugh, Alfonso Urbanucci, Nihal E Mohamed

|Apr 19, 2022
Prostate MRI percentage tumor involvement or "PI-RADS percent" as a predictor of adverse surgical pathology.

Parita Ratnani, Zach Dovey, Sneha Parekh

|Sep 01, 2020
The Resilient Child: Sex-Steroid Hormones and COVID-19 Incidence in Pediatric Patients.

Meredith Mihalopoulos, Alice C Levine, Naoum Fares Marayati

|Jun 17, 2020
Androgens modify therapeutic response to cabazitaxel in models of advanced prostate cancer.

Diane Begemann, Yang Wang, Wei Yang

Pageof 2

Frequent Collaborators

1 joint publications

Parita Ratnani

1 joint publications

Dana Cavanaugh

1 joint publications

Lars Björnebo

1 joint publications

Shirin Razdan